COVID-19: Blood cancer patients gain antibodies from vaccine booster - study

Blood cancer patients, already at high risk, often did not develop antibodies against COVID-19 from the first shot. But the booster and antibody therapy can provide a better shield.

An undated transmission electron micrograph of SARS-CoV-2 virus particles, also known as novel coronavirus, the virus which causes COVID-19, isolated from a patient.

(photo credit: NIAID INTEGRATED RESEARCH FACILITY (IRF)/HANDOUT VIA REUTERS)

ByAARON REICH

JULY 11, 2022 12:44

Updated: JULY 11, 2022 12:51

RECOMMENDED STORIES

Palestinian Hamas terrorists keep guard on the day Hamas handed over deceased hostages in Khan Younis in the southern Gaza Strip February 20, 2025.

Admitting defeat? Why Hamas officials say the terror group 'lost control' of Gaza

JULY 7, 2025

Members of Hamas with the backdrop of the Gaza Strip, amid reports that Hamas has lost control of much of its territory.

'Security situation has collapsed': Hamas has lost 80% of its control over Gaza Strip

JULY 7, 2025

Reporter's Notebook: 'Post' meets with top Hebron sheikh who wants to pull out of PA

JULY 6, 2025

IDF Maj.-Gen. Aviad Dagan entering a fighter jet; illustrative.

IDF cyber chief, retired Iran strategy head piloted fighter jets striking Iran

JULY 6, 2025

Hot Opinion

War doesn't end on the battlefield: Israel must better support veterans with PTSD

ByJPOST EDITORIAL

Israel's midnight strategist: How IDF chief Eyal Zamir rewired the doctrine on Iran

ByZVIKA KLEIN, YONAH JEREMY BOB

As thousands stay away, Ethiopian Israelis pay a heavy price in Gaza war

ByYAAKOV KATZ

Can Donald Trump win a Nobel Peace Prize?

ByAMOTZ ASA-EL